Arkolith/Insider Trading/QSAM/Form 4/A

Baum Douglas R

CEO/Director, DirectorQSAM Biosciences, Inc. (QSAM) · full profile →Form 4/A · filed Feb 14, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 6, 2024Conversion(C)1K$3.00$4K377K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 6, 2024Conversion(C)0—$00

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001493152-24-006713) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML